CLEC10A Antibody (N-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q8IUN9 |
---|---|
Other Accession | NP_878910.1, NP_006335.2 |
Clone Names | 91230197 |
Gene ID | 10462 |
---|---|
Other Names | C-type lectin domain family 10 member A, C-type lectin superfamily member 14, Macrophage lectin 2, CD301, CLEC10A, CLECSF13, CLECSF14, HML |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | CLEC10A |
---|---|
Synonyms | CLECSF13, CLECSF14, HML |
Function | Probable role in regulating adaptive and innate immune responses. Binds in a calcium-dependent manner to terminal galactose and N-acetylgalactosamine units, linked to serine or threonine. These sugar moieties are known as Tn-Ag and are expressed in a variety of carcinoma cells. |
Cellular Location | Membrane; Single-pass type II membrane protein |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
CLEC10A encodes a member of the C-type lectin/C-typelectin-like domain (CTL/CTLD) superfamily. Members of this familyshare a common protein fold and have diverse functions, such ascell adhesion, cell-cell signalling, glycoprotein turnover, androles in inflammation and immune response. The encoded type 2transmembrane protein may function as a cell surface antigen. Twotranscript variants encoding distinct isoforms have been identifiedfor this gene.
References
Davila, S., et al. Genes Immun. 11(3):232-238(2010)Iijima, M., et al. Neurology 73(17):1348-1352(2009)van Vliet, S.J., et al. PLoS Pathog. 5 (10), E1000625 (2009) :Suzuki, N., et al. J. Immunol. 156(1):128-135(1996)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.